Table 2.
Immunophenotype of ASCs cultured in CM from bladder cancer cells.
| CD44 | CD73 | CD90 | CD105 | |||||
|---|---|---|---|---|---|---|---|---|
| Positive Cells [%] | IF Intensity | Positive Cells [%] | IF Intensity | Positive Cells [%] | IF Intensity | Positive Cell [%] | IF Intensity | |
| 5637 | 99.1 (0.3) | 74.2 (15.7) | 99.6 (0.4) | 146.2 (8.4) * | 97.4 (3.2) | 69.9 (4.1) | 94.9 (1.8) | 49.0 (3.5) * |
| HB-CLS-1 | 99.0 (0.4) | 80.9 (14.5) | 99.2 (0.7) | 144.8 (1.7) * | 97.4 (2.8) | 68.3 (6.1) * | 94.2 (2.5) | 46.0 (3.0) * |
| HT-1376 | 99.5 (0.3) | 79.0 (7.8) | 99.6 (0.3) | 132.2 (4.1) * | 97.8 (2.8) | 67.5 (12.8) * | 95.1 (2.2) | 63.2 (2.3) * |
Standard deviation is given in brackets. Immunofluorescence intensity is shown as the percentage of control. Standard deviation is given in brackets; * p < 0.05.